The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Par Pharmaceutical Companies Inc  (PRX) Trade Now »     Rate PRX  -  Discuss PRX  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate PRX:



PRX Analysis & Videos »


PRX: Bull or Bear?

Par Pharma and BioAlliance: Pipeline Analysis Graphic_rating_buy PRX
Mikerun
73%
 +109.52%
in 230 days

MonoSol Rx, the developers of PharmFilm(R) technology and a drug delivery company specializing in dissolving thin film pharmaceutical products, and Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: PRX), announced the submission on April 7, 2009 of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the orally dissolving film strip (ODFS) formulation of ondansetron.

<> <> The NDA is supported by positive data from completed pivotal studies in which ondansetron ODFS demonstrated bioequivalence against G...
By  Mike Havrilla   (+1.04%  risk: conservative)  04/19/09 Comment


Updated FDA, Clinical Trial Calendars: CRME, MRK, LLY, PRX Graphic_rating_buy PRX
Mikerun
73%
 -0.53%
in 9 days
(closed on 04/19/09)
Below is a summary of updates to the BioMedReports.com database of 242 entries included in the FDA and Clinical Trial Calendars .
 
 
<> The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. The entries are updated on a daily basis as new information becomes available with a total of 115 entries through 4/9/09. The FDA Calendar includes the following information: company name, ticker, decision ...
By  Mike Havrilla   (+1.04%  risk: conservative)  04/10/09 Comment


Bullish on PRX ... Graphic_rating_buy PRX
Foto
62%
 +145.66%
in 277 days
Par Pharmaceutical Companies, Inc., through its subsidiary, Par Pharmaceutical, Inc. develops, manufactures, and distributes generic and branded pharmaceuticals drugs in the United States. The company offers generic prescription drugs consisting of approximately 180 products representing various dosage strengths for approximately 80 separate drugs. Its generic products include metoprolol, fluticasone, propranolol ER, cabergoline, amoxicillin, ibuprofen Rx, tramadol HCl and acetaminophen tablets, megestrol oral suspension, fluoxetine, and methimazole. The company offers its drugs in the soli...
By  Marian Filo   (-24.55%  risk: aggressive)  03/03/09 Comment


Get free stock alert for PRX:
Your Email Address:





People Bullish on PRX

Ace_spades
jonock
Analyst
N/A
about 1 mo ago

Mikerun
Mike Havrilla
Principal
73%
7 mos ago

Foto
Marian Filo
Principal
62%
9 mos ago

Statistician
Analyst
N/A
about 1 year ago

Art
Analyst
N/A
about 1 year ago


People Bearish on PRX

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +71.24% 211
3 stockmarketfunding.com 17.66 +25.60% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment
T AT&T Inc
BIDU Baiducom Inc ADS
FNM Fannie Mae
NVDA NVIDIA Corp
GS Goldman Sachs Group Inc The
WM Washington Mutual Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on PRX


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Par Pharmaceutical Companies Inc - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch